Leveraging Digital Health Technologies and Outpatient Sampling in Clinical Drug Development: A Phase I Exploratory Study

MLA

Marissa F. Dockendorf, et al. “Leveraging Digital Health Technologies and Outpatient Sampling in Clinical Drug Development: A Phase I Exploratory Study.” Clinical Pharmacology & Therapeutics, vol. 105, July 2018, pp. 168–76. EBSCOhost, https://doi.org/10.1002/cpt.1142.

APA

Marissa F. Dockendorf, Kevin P. Bateman, Iris Xie, Matthew Moyer, Jane Harrelson, Gowri Murthy, Andra Goldman, Jyoti Shah, Melanie Anderson, Rachel Ruba, Rubi Burlage, Jeffrey R. Sachs, Lisa A. Shipley, & Prajakti A. Kothare. (2018). Leveraging Digital Health Technologies and Outpatient Sampling in Clinical Drug Development: A Phase I Exploratory Study. Clinical Pharmacology & Therapeutics, 105, 168–176. https://doi.org/10.1002/cpt.1142

Chicago

Marissa F. Dockendorf, Kevin P. Bateman, Iris Xie, Matthew Moyer, Jane Harrelson, Gowri Murthy, Andra Goldman, et al. 2018. “Leveraging Digital Health Technologies and Outpatient Sampling in Clinical Drug Development: A Phase I Exploratory Study.” Clinical Pharmacology & Therapeutics 105 (July): 168–76. doi:10.1002/cpt.1142.